Actively Recruiting
Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
Led by Stony Brook University · Updated on 2025-06-08
50
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if the OTC supplement, hydrogen water, works to treat the fatigue-related symptoms and functional limitations in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). It will also examine if heart rate variability (HRV) can be used to predict who will benefit from the hydrogen water treatment. The main questions it aims to answer are: Does the OTC supplement, hydrogen water, work to reduce the fatigue-related symptoms and improve functioning in participants who have ME/CFS? Can HRV be used to predict who will benefit from treatment with hydrogen water?
CONDITIONS
Official Title
Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meets Institute of Medicine criteria for myalgic encephalomyelitis/chronic fatigue syndrome
You will not qualify if you...
- Medical illness that explains presenting fatigue
- Any psychosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stony Brook University
Stony Brook, New York, United States, 11794-8101
Actively Recruiting
Research Team
F
Fred Friedberg, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here